SLS BIO Co., Ltd (KOSDAQ:246250)
South Korea · Delayed Price · Currency is KRW 1,969.00
+85.00 (4.51%)
At close: Jun 9, 2025
SLS BIO Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2015 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '15 Dec 31, 2015 |
Net Income | -5,644 | -4,904 | 335.63 | 1,434 | 2,826 | 204.47 |
Depreciation & Amortization | 1,266 | 1,283 | 1,336 | 1,278 | 1,303 | 616.03 |
Loss (Gain) From Sale of Assets | - | -0.14 | 0 | 0.01 | -40.3 | -4 |
Loss (Gain) on Equity Investments | - | - | - | 39.06 | 236.35 | - |
Stock-Based Compensation | - | 0.29 | 3.75 | 11.77 | 32.79 | - |
Provision & Write-off of Bad Debts | 4 | 4 | 77.64 | 133.87 | 34.87 | 21.57 |
Other Operating Activities | 852.66 | 791.6 | 467.69 | -139.84 | -278.15 | 324.4 |
Change in Accounts Receivable | 689.98 | 1,166 | 118.11 | 1,076 | -202.97 | -564.81 |
Change in Inventory | 1.35 | 1.35 | 8.64 | 74.96 | -99.5 | - |
Change in Accounts Payable | -130.29 | -243.79 | -472.39 | 339.59 | 82.83 | 14.99 |
Change in Other Net Operating Assets | -226.98 | -293.02 | -149.13 | -812.36 | 138.74 | 112.13 |
Operating Cash Flow | -3,187 | -2,195 | 1,726 | 3,436 | 4,034 | 724.79 |
Operating Cash Flow Growth | - | - | -49.76% | -14.83% | 456.58% | -17.73% |
Capital Expenditures | -1,549 | -1,514 | -1,456 | -1,274 | -719.23 | -627.13 |
Sale of Property, Plant & Equipment | - | 0.2 | - | - | 203.64 | 4 |
Sale (Purchase) of Intangibles | -14.82 | -17.53 | -43.37 | -134.44 | -15.39 | -348.6 |
Investment in Securities | 4,523 | 3,490 | 997.32 | -6,509 | -1,012 | -1,499 |
Other Investing Activities | -15 | -15 | -0 | -0.78 | -0.52 | -71.52 |
Investing Cash Flow | 2,944 | 1,944 | -502.34 | -7,918 | -1,543 | -2,538 |
Long-Term Debt Issued | - | - | - | - | - | 200 |
Total Debt Issued | - | - | - | - | - | 200 |
Short-Term Debt Repaid | - | - | - | - | -1,770 | -312 |
Long-Term Debt Repaid | - | -614.99 | -589.58 | -579.91 | -574.71 | -1,124 |
Total Debt Repaid | -622.27 | -614.99 | -589.58 | -579.91 | -2,345 | -1,436 |
Net Debt Issued (Repaid) | -622.27 | -614.99 | -589.58 | -579.91 | -2,345 | -1,236 |
Issuance of Common Stock | - | - | - | 5,660 | - | 3,626 |
Repurchase of Common Stock | - | - | -899.88 | - | - | - |
Dividends Paid | - | - | -383.71 | - | - | - |
Other Financing Activities | - | - | -27.8 | -302.2 | - | -187.77 |
Financing Cash Flow | -622.27 | -614.99 | -1,901 | 4,777 | -2,345 | 2,203 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | - | -0 | - |
Net Cash Flow | -865.26 | -865.94 | -677.09 | 294.84 | 146.05 | 389.11 |
Free Cash Flow | -4,736 | -3,709 | 269.92 | 2,162 | 3,315 | 97.66 |
Free Cash Flow Growth | - | - | -87.51% | -34.79% | 3294.14% | -88.45% |
Free Cash Flow Margin | -148.62% | -93.09% | 3.22% | 23.96% | 30.83% | 1.57% |
Free Cash Flow Per Share | -320.98 | -246.45 | 17.69 | 153.75 | 483.26 | 19.58 |
Cash Interest Paid | - | - | - | - | 23.37 | 175.57 |
Cash Income Tax Paid | - | -16.42 | 36.53 | 6.47 | 1.09 | 3.06 |
Levered Free Cash Flow | -2,464 | -1,893 | -3.66 | 1,255 | - | -559.57 |
Unlevered Free Cash Flow | -2,425 | -1,852 | 48.79 | 1,318 | - | -349.34 |
Change in Working Capital | 334.05 | 630.3 | -494.76 | 678.68 | -80.9 | -437.68 |